DOV 216,303, >=98% (HPLC)

Code: D6446-25MG D2-231

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Triple reuptake inhibitor (TRI); serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI); IC50 values of ~20, 14, and 78 nM, respectively.

...


 Read more

Your Price
$534.44 25MG
REQUEST

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Triple reuptake inhibitor (TRI); serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI); IC50 values of ~20, 14, and 78 nM, respectively.

Features and Benefits

This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is featured on the Dopamine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Packaging

5, 25 mg in glass bottle

assay≥98% (HPLC)
colorwhite to beige
formpowder
InChI keyKAGBHVBIOJBGBD-UHFFFAOYSA-N
InChI1S/C11H11Cl2N.ClH/c12-9-2-1-7(3-10(9)13)11-4-8(11)5-14-6-11;/h1-3,8,14H,4-6H2;1H
originatorMerck & Co., Inc., Kenilworth, NJ, U.S.
Quality Level100
SMILES stringCl.Clc1ccc(cc1Cl)C23CNCC2C3
solubilityDMSO: ≥10 mg/mL
storage temp.−20°C
Cas Number0086215-36-3
Hazard Class6.1
Un Number2811
Pack Group3
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.